l-[METHYL-11C] Methionine Positron Emission Tomography for Target Delineation in Malignant Gliomas: Impact on Results of Carbon Ion Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 515-522

  Mahasittiwat, Pawinee ^a   Mizoe, Jun etsu ^b   Hasegawa, Azusa ^b   Ishikawa, Hiroyuki ^b   Yoshikawa, Kyosan ^b   Mizuno, Hideyuki ^b   Yanagi, Takeshi ^b   Takagi, Ryou ^b   Pattaranutaporn, Pittayapoom ^a   Tsujii, Hirohiko ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Carbon ion radiotherapy; Image fusion; Malignant gliomas; Methionine positron emission tomography (PET); Treatment planning

Indexed keywords

CARBON; COMPUTERIZED TOMOGRAPHY; IMAGE FUSION; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

CARBON ION RADIOTHERAPY; TREATMENT PLANNING;

RADIOTHERAPY;

CARBON; METHIONINE C 11;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; ION THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 38149133249     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.071     Document Type: Article

References (39)

1. Leibel S.A., Scott C.B., and Loeffler J.S. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 21 (1994) 198-219
2. Walker M.D., Strike T.A., and Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5 (1979) 1725-1731
3. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303 (1980) 1323-1329
4. Shapiro W.R., Green S.B., Burger P.C., et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 71 (1998) 1-9
5. Byrne T.N. Imaging of gliomas. Semin Oncol 21 (1994) 162-171
6. Sartor K. MR imaging of the brain tumors. Eur Radiol 9 (1999) 1047-1054
7. Galanis E., Buckner J.C., Novotny P., et al. Efficacy of neuroradiological imaging, neurological examination, and symptoms status in follow-up assessment of patients with high grade gliomas. J Neurosurg 93 (2000) 201-207
8. Hochberg F.H., and Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 30 (1980) 907-911
9. Burger P.C., Dubois P.J., Schold S.C., et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58 (1983) 159-169
10. Halperin E.C., Bentel G., Heinz E.R., et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 17 (1989) 1347-1350
11. Kelly P.J., Daumas-Duport C., Kispert D.B., et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66 (1987) 865-874
12. Watanabe M., Tanaka R., and Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34 (1992) 463-469
13. Johnson P.C., Hunt S.J., and Drayer B.P. Human cerebral gliomas: Correlation of postmortem MR imaging and neuropathologic findings. Radiology 170 (1989) 211-217
14. Ten Haken R.K., Thornton A.F., Sandier H.M., et al. A quantitative assessment of the addition of MRI to CT-based 3-D treatment planning of brain tumors. Radiother Oncol 25 (1992) 121-133
15. Thornton A.F., Sandier H.M., Ten Haken R.K., et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 24 (1992) 767-775
16. Kelly P.J., Daumas-Duport C., and Scheitauer B.W. Stereotactic histologic correlations of CT- and MRI-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62 (1987) 450-459
17. Chamberlain M.C., Murovic J.A., and Levin V.A. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38 (1988) 1371-1374
18. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
19. Chapman J.D., Bradley J.D., Eary J.F., et al. Molecular (functional) imaging for radiotherapy applications: An RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
20. Grosu A.L., Weber W.A., Franz M., et al. Reirradiation of recurrent high grade gliomas using amino-acids-PET(SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 511-519
21. 18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med 40 (1999) 1367-1373
22. 18F)-FDG uptake in rat C6 glioma cells. Strahlenther Onkol 180 (2004) 434-441
23. 123I]Iodo-alpha-methyl-l-tyrosine uptake in cerebral gliomas: Relationship to histological grading and prognosis. Eur J Nucl Med 28 (2001) 855-861
24. 11C]methionine. J Comput Assist Tomogr 7 (1983) 1062-1066
25. Mosskin M.E.K., Hindmarsh T., Holst H., et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30 (1989) 225-232
26. Ogawa T., Shishido F., Kanno I., et al. Cerebral glioma: Evaluation with methionine PET. Radiology 186 (1993) 45-53
27. 11)C methionine positron emission tomography (PET): Data results of a pilot study in 32 surgical cases. Acta Neurochir (Wien) 144 (2002) 777-782 discussion, 782
28. 11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 64-74
29. 11C]methionine. J Nucl Med 28 (1987) 1037-1040
30. 123I]iodo-L-α-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 42 8 (2001) 1144-1150
31. Coleman R.E., and Wong T.Z. Brain tumors: Astrocytomas, oligodendrigliomas, and glioblastomas. Clinical molecular anatomic imaging (2003), Lippincott Williams & Wilkins, Ambler, PA 158-168
32. Isselbacher K.J. Sugar and amino acid transport by cells in culture: Differences between normal and malignant cells. N Engl J Med 286 (1972) 929-933
33. Conti P.S. Introduction to imaging brain tumor metabolism with positron emission tomography (PET). Cancer Invest 13 (1995) 244-259
34. 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9 (1985) 683-689
35. Weber W.A., Avril N., and Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkol 175 (1999) 356-373
36. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45 (2004) 1293-1298
37. 11C-methionine and computed tomography of intracranial tumors compared with histopathologic examination of multiple biopsies. Acta Radiol 28 (1987) 673-681
38. Tovi M., Lilja A., Bergstrom M., et al. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol 31 (1990) 417-429
39. Torii K., Tsuyuguchi N., Kawabe J., et al. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med 19 (2005) 677-683